In the treatment of COVID-19, ivermectin use is associated with decreased mortality compared to remdesivir use, according to a study published in the International Journal of Infectious Diseases.
Researchers at the University of Miami retrospectively analyzed a national federated database of adults aged 18 and older with a recorded COVID-19 infection between January 2020 and July 2021.
